HEC
Hudson Executive Capital Portfolio holdings
AUM
$135M
This Quarter Return
+1.7%
1 Year Return
+30.05%
3 Year Return
+142.48%
5 Year Return
+146.32%
10 Year Return
–
AUM
$1.04B
AUM Growth
+$1.04B
(+9.7%)
Cap. Flow
+$58M
Cap. Flow
% of AUM
5.6%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
12
New
1
Increased
1
Reduced
2
Closed
–
Top Buys
| 1 |
TVTY
Tivity Health, Inc. Common Stock
TVTY
|
$39M |
| 2 |
Cantaloupe
CTLP
|
$21.6M |
Top Sells
| 1 |
AtriCure
ATRC
|
$2.49M |
| 2 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
$79.9K |
Sector Composition
| 1 | Financials | 46.88% |
| 2 | Industrials | 23.72% |
| 3 | Healthcare | 15.48% |
| 4 | Technology | 7.17% |
| 5 | Materials | 3.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Deutsche Bank
DB
$67.7B
| $486M | 36.75% |
64,861,476
| – | – |
|
|
CATM
2
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $246M | 18.59% |
8,126,933
| – | – |
|
|
3
Cantaloupe
CTLP
$797M
| $74.3M | 5.62% |
10,140,172
+2,944,452
| +41% | +$21.6M |
|
|
CVRS
4
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $60.9M | 4.61% |
14,235,545
| – | – |
|
|
EGRX
5
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $45.8M | 3.47% |
810,365
-1,412
| -0.2% | -$79.9K |
|
|
TVTY
6
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $39M | 2.95% |
+2,346,560
| New | +$39M |
|
7
ScottsMiracle-Gro
SMG
$3.53B
| $36.7M | 2.78% |
360,275
| – | – |
|
|
STOR
8
DELISTED
STORE Capital Corporation
STOR
| $33.3M | 2.52% |
890,800
| – | – |
|
9
Natera
NTRA
$23.1B
| $12.4M | 0.94% |
378,589
| – | – |
|
|
10
AtriCure
ATRC
$1.84B
| $2.19M | 0.17% |
87,678
-100,000
| -53% | -$2.49M |
|
11
iShares Russell 2000 ETF
IWM
$67B
| – | – |
0
| – | – |
|
12
SPDR S&P 500 ETF Trust
SPY
$658B
| – | – |
0
| – | – |
|